Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
23,031.60
(
-2.05%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
102.13
(
1.45%
)
Bitcoin
68,752.00
(
-0.05%
)
News Focus
News Focus
Post# of 30495
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122815
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 16502

Wednesday, 04/18/2018 3:55:19 PM

Wednesday, April 18, 2018 3:55:19 PM

Post# of 30495
ABT 1Q18 sales by business segment: 
 Medical devices  37% (+5% YoY in const currency)  
 Diagnostics      25% (+6% YoY in const currency)  
 Nutrition        24% (+5% YoY in const currency) 
 Pharmaceuticals† 14% (+7% YoY in const currency)
64% of overall sales were ex-US.

†Ex-US branded generics.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today